Helicobacter pylori
Material: | Pathogen detection: Gastric / duodenal biopsy in special transport medium Antibody detection: 1 lm serum PCR: Stool |
Methods: |
Amplifikationsverfahren → Real-time-PCR Ligandenassays → Enzyme Linked Immunosorbent Assay (ELISA) Kulturelle Untersuchungen → mikroaerophiler Atmosphäre | Reference range | IgG: < 20 U/ml IgA: < 20 U/ml PCR: negative |
Indication | Gastritis, ventricular ulcer, duodenal ulcer, gastric MALT-lymphoma, idiopathic thrombocytopenic purpura, possibly M. Menetrier, functional dyspepsia (debated) |
Please note | H. pylori prevalence in Germany is between 3 % (children) and 48 % (adults). It is markedly increased in immigrants (36 % - 86 %). 80 % of the infections are clinically symptomless. H. pylori may trigger chronic active gastritis. Potential consequences are duodenal or ventricular ulcers, adenocarcinoma of the stomach or MALT-syndrome. Taking proton pump inhibitors (PPI) and antibiotics, reduces pathogen density. This may lead to false negative results. Therefore, diagnostics should take place no earlier than 4 weeks after antibiotic treatment and at least 2 weeks after PPI treatment. Diagnostic via culture and PCR from biopsies taken endoscopically (invasive method) or via non-invasive methods such as urea breath test, PCR, IgG- and IgA antibodies in serum. An acute infection can be demonstrated by culture, PCR or urea breath test. A positive serological result only shows, that a previous confrontation with bacteria has taken place, it does not allow a statement about infection activity. Following sanitization, a significant fall in titer can be seen after 6 – 12 months. A false-negative serum test can be caused by missing immune answer. A resistance test is possible from a culture from gastric- / duodenal biopsies, testing for clarithromycin resistance by PCR is also possible from those kind of biopsies or stool. For initial diagnosis in children and for follow-up checks after eradication treatment in adults, the breath test (C13-urea breath test- only suitable for older children from the age of 8- please refer to function tests), or PCR are recommended. Checks of eradication treatment should be carried out no earlier than 4 weeks after therapy end. Please also refer to section “Helicobacter pylori C13 breath test” |
Accredited | ja |
More Results for the letter H
- H2 breath test (H2ATEM)
- Lactose-H2 breath test, fructose-H2 breath test, sorbit-H2 breath test, glucose-H2 breath test
- Hair analysis for drugs (HAIR01)
- opiates, methadon, cannabis, amphetamines, methamphetamines, cocaine
- Hair analysis for metals (HAARE2)
- Arsenic, lead, cadmium, copper, mercury, palladium, zinc and others
- Haloperidol (HAL)
- HAMA (HAMA)
- human anti-mouse antibodies
- Hanta viruses (HANTAV)
- Serotypes Hantaan, Seoul, Puumala
- Haptoglobin (HP)
- HBDH (HBDH)
- Alpha-hydroxybutyric dehydrogenase, LDH1
- HBV resistance/subtype (HBVTDF)
- HCG in serum (β-) (HCG(b))
- human chorionic gonadotropin
- HCG in urine (β-) (HCG(b))
- human chorionic gonadotropin
- HDL cholesterol (HDL)
- HE 4 (HE 4)
- Human epididymis protein
- Helicobacter pylori (KHELI, PHELI)
- Helicobacter pylori 13C breath test (ATEMB)
- HELLP syndrome (HELLP)
- Hemochromatosis gene mutation (HLAH)
- HFE gene mutation
- Hemoglobin A1c (HBAAC)
- HbA1c
- Hemoglobin F cells (HBFZ)
- Fetal erythrocytes, fetomaternal transfusion
- Hemoglobin, free (FRHB)
- Hemoglobin-electrophoresis (HBL)
- Hemoglobinopathy, molecular genetic evaluation (HMO)
- Hemolysins (KAEH)
- Hemophilus ducreyi (HAEDUC)
- Soft chancre
- Hemophilus influenzae (KHAEM, HAEINF)
- Hemorrhagic fever, viral (VHF)
- Heparin platelet factor 4 complex antibodies (HIPAHE)
- HIT-diagnostics
- Heparin, low molecular weight (AFXAL)
- LMW heparin
- Hepatitis A (HAV)
- Hepatitis B (AHBC)
- Anti-HBc-IgG